全文获取类型
收费全文 | 6711篇 |
免费 | 403篇 |
国内免费 | 141篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 172篇 |
妇产科学 | 60篇 |
基础医学 | 882篇 |
口腔科学 | 15篇 |
临床医学 | 668篇 |
内科学 | 2085篇 |
皮肤病学 | 30篇 |
神经病学 | 118篇 |
特种医学 | 176篇 |
外国民族医学 | 1篇 |
外科学 | 531篇 |
综合类 | 647篇 |
现状与发展 | 1篇 |
预防医学 | 1025篇 |
眼科学 | 10篇 |
药学 | 327篇 |
3篇 | |
中国医学 | 55篇 |
肿瘤学 | 428篇 |
出版年
2023年 | 381篇 |
2022年 | 398篇 |
2021年 | 478篇 |
2020年 | 740篇 |
2019年 | 337篇 |
2018年 | 338篇 |
2017年 | 284篇 |
2016年 | 276篇 |
2015年 | 321篇 |
2014年 | 559篇 |
2013年 | 378篇 |
2012年 | 294篇 |
2011年 | 290篇 |
2010年 | 339篇 |
2009年 | 297篇 |
2008年 | 170篇 |
2007年 | 195篇 |
2006年 | 144篇 |
2005年 | 134篇 |
2004年 | 125篇 |
2003年 | 130篇 |
2002年 | 141篇 |
2001年 | 106篇 |
2000年 | 71篇 |
1999年 | 75篇 |
1998年 | 53篇 |
1997年 | 25篇 |
1996年 | 35篇 |
1995年 | 3篇 |
1994年 | 12篇 |
1993年 | 8篇 |
1992年 | 26篇 |
1991年 | 19篇 |
1990年 | 15篇 |
1989年 | 10篇 |
1988年 | 3篇 |
1987年 | 2篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 7篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 4篇 |
1979年 | 4篇 |
1977年 | 5篇 |
1976年 | 3篇 |
1975年 | 1篇 |
1970年 | 1篇 |
1969年 | 1篇 |
排序方式: 共有7255条查询结果,搜索用时 468 毫秒
1.
2.
3.
4.
《Vaccine》2020,38(23):3934-3941
IntroductionSubjects with rheumatoid arthritis (RA) receiving tumor necrosis factor-inhibiting (TNFi) therapies are at risk for severe influenza, and may respond less well to influenza vaccine. We examined the safety and immunogenicity of high dose influenza vaccine (HD) compared to standard dose vaccine (SD) in participants with RA receiving stable TNFi.MethodsA randomized, double-blinded, Phase II study was conducted in adults with RA receiving TNFi, and healthy, gender and age-matched control subjects. Participants were immunized with HD (Sanofi Pasteur Fluzone High Dose [60 mcg × 3 strains]) or SD (Sanofi Pasteur Fluzone® [15 mcg × 3 strains]) intramuscularly (IM). A self-administered memory aid recorded temperature and systemic and local adverse events (AEs) for 8 days, and safety was evaluated and serum obtained to measure HAI activity on days 7, 21 and 180 days following vaccination.ResultsA greater proportion of RA subjects who received HD seroconverted at day 21 compared to SD, although this was not statistically significant. GMT antibody responses in RA subjects who received HD compared to SD were greater for all strains on day 21, and this was significant for H1N1. Seroconversion rates and GMT values were not different between RA subjects and control subjects. There were no safety concerns for HD or SD in RA subjects, and RA-related symptoms did not differ between SD and HD recipients by a RA-symptom questionnaire (RAPID 3).ConclusionsTNF-inhibitor therapy in people with RA did not appear to influence the immunogenicity of either SD or HD. Influenza seroconversion and GMT values were higher among RA subjects receiving HD compared to SD; however, differences were small and a larger study is needed to validate these findings. Given the apparent risk of increased influenza-related morbidity and mortality among immune compromised subjects, the higher GMT values generated by HD may be beneficial. 相似文献
5.
6.
7.
8.
《Vaccine》2020,38(42):6508-6516
BackgroundPneumococcal conjugate vaccine (PCV) effectiveness against radiographic pneumonia in South Asia is unknown. Bangladesh introduced PCV10 in 2015 using a three dose primary series (3 + 0). We sought to measure PCV10 effectiveness for two or more vaccine doses on radiographic pneumonia among vaccine-eligible children in rural Bangladesh.MethodsWe conducted a matched case-control study over two years from 2015 to 2017 using clinic and community controls in three subdistricts of Sylhet, Bangladesh. Cases were vaccine eligible 3–35 month olds at Upazila Health Complex outpatient clinics with World Health Organization-defined radiographic primary endpoint pneumonia (radiographic pneumonia). Clinic controls were matched to cases within a one week time window by age, sex, and clinic and had an illness unlikely to be Streptococcus pneumoniae; community controls were healthy and similarly matched within a one week time window by age and sex, and distance from the clinic. We estimated adjusted vaccine effectiveness (aVE) using conditional logistic regression.ResultsWe matched 1262 cases with 2707 clinic and 2461 community controls. Overall, aVE using clinic controls was 21.4% (95% confidence interval, −0.2%, 38.4%) for ≥2 PCV10 doses and among 3–11 month olds was 47.3% (10.5%, 69.0%) for three doses. aVE increased with higher numbers of doses in clinic control sets (p = 0.007). In contrast, aVE using community controls was 7.6% (95% confidence interval, −22.2%, 30.0%) for ≥2 doses. We found vaccine introduction in the study area faster and less variable than expected with 75% coverage on average, which reduced power. Information bias may also have affected community controls.ConclusionsClinic control analyses show PCV10 prevented radiographic pneumonia in Bangladesh, especially among younger children receiving three doses. While both analyses were underpowered, community control enrollment – compared to clinic controls – was more difficult in a complex, pluralistic healthcare system. Future studies in comparable settings may consider alternative study designs. 相似文献
9.
10.